162(top 1%)
PR articles
13.9K(top 1%)
PR citations
67(top 1%)
PR h-index
71(top 1%)
h-index
192
documents
17.8K
doc citations
2.3K
citing journals
100
times ranked

Publications

167 peer-reviewed articles • 14,690 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Blocking MIF secretion enhances CAR T-cell efficacy against neuroblastoma
European Journal of Cancer, 2025, 218, 115263
4.919Citations (PDF)
2A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence
Cancer Research Communications, 2025, 5, 580-593
2.81Citations (PDF)
3A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches
Briefings in Bioinformatics, 2025, 26,
6.6119Citations (PDF)
4Proteomic-based stratification of intermediate-risk prostate cancer patients
Life Science Alliance, 2024, 7, e202302146
2.619Citations (PDF)
5Heat ‘n Beat: A Universal High-Throughput End-to-End Proteomics Sample Processing Platform in under an Hour
Analytical Chemistry, 2024, 96, 4093-4102
6.515Citations (PDF)
6DeePathNet: A Transformer-Based Deep Learning Model Integrating Multiomic Data with Cancer Pathways
Cancer Research Communications, 2024, 4, 3151-3164
2.827Citations (PDF)
7Quantitative proteomic studies addressing unmet clinical needs in sarcoma
Frontiers in Oncology, 2023, 13,
2.612Citations (PDF)
8qmotif: determination of telomere content from whole-genome sequence data
Bioinformatics Advances, 2022, 2,
2.415Citations (PDF)
9Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina
Frontiers in Neuroscience, 2022, 16,
2.78Citations (PDF)
10Pan-cancer proteomic map of 949 human cell lines
Cancer Cell, 2022, 40, 835-849.e8
33.0221Citations (PDF)
11TOP3A amplification and ATRX inactivation are mutually exclusive events in pediatric osteosarcomas using ALT
EMBO Molecular Medicine, 2022, 14,
7.140Citations (PDF)
12Targeted Therapy of TERT -Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
Clinical Cancer Research, 2021, 27, 1438-1451
6.833Citations (PDF)
13Alternative lengthening of telomeres is not synonymous with mutations in ATRX/DAXX
Nature Communications, 2021, 12,
13.740Citations (PDF)
14Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells
Scientific Reports, 2021, 11,
3.48Citations (PDF)
15A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region
EJHaem, 2021, 2, 157-166
1.62Citations (PDF)
16The C-Circle Biomarker Is Secreted by Alternative-Lengthening-of-Telomeres Positive Cancer Cells inside Exosomes and Provides a Blood-Based Diagnostic for ALT Activity
Cancers, 2021, 13, 5369
3.826Citations (PDF)
17Role of POT1 in Human Cancer
Cancers, 2020, 12, 2739
3.864Citations (PDF)
18Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development
Cell Reports, 2020, 31, 107802
6.333Citations (PDF)
19Strategies to enable large-scale proteomics for reproducible research
Nature Communications, 2020, 11,
13.7135Citations (PDF)
20Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
Cancers, 2020, 12, 2472
3.830Citations (PDF)
21End Products of Telomere Research
Cell Stem Cell, 2020, 26, 804-805
16.40Citations (PDF)
22The FANCM-BLM-TOP3A-RMI complex suppresses alternative lengthening of telomeres (ALT)
Nature Communications, 2019, 10,
13.7196Citations (PDF)
23Synthetic lethality of cytolytic HSV-1 in cancer cells with ATRX and PML deficiency
Journal of Cell Science, 2019, ,
2.422Citations (PDF)
24∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
Nature Communications, 2018, 9,
13.775Citations (PDF)
25Telomere sequence content can be used to determine ALT activity in tumours
Nucleic Acids Research, 2018, 46, 4903-4918
15.549Citations (PDF)
26Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten
Epigenetics and Chromatin, 2018, 11,
3.246Citations (PDF)
27Limiting Thymic Precursor Supply Increases the Risk of Lymphoid Malignancy in Murine X-Linked Severe Combined Immunodeficiency
Molecular Therapy - Nucleic Acids, 2017, 6, 1-14
5.524Citations (PDF)
28Whole-genome landscape of pancreatic neuroendocrine tumours
Nature, 2017, 543, 65-71
37.9946Citations (PDF)
29Withaferin-A kills cancer cells with and without telomerase: chemical, computational and experimental evidences
Cell Death and Disease, 2017, 8, e2755-e2755
8.558Citations (PDF)
30BLM and SLX4 play opposing roles in recombination‐dependent replication at human telomeres
EMBO Journal, 2017, 36, 2907-2919
7.3174Citations (PDF)
31MatCol: a tool to measure fluorescence signal colocalisation in biological systems
Scientific Reports, 2017, 7,
3.422Citations (PDF)
32Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres
Cell Reports, 2017, 19, 2544-2556
6.397Citations (PDF)
33Comparative analysis of whole genome sequencing-based telomere length measurement techniques
Methods, 2017, 114, 4-15
3.557Citations (PDF)
34The C-Circle Assay for alternative-lengthening-of-telomeres activity
Methods, 2017, 114, 74-84
3.5133Citations (PDF)
35Is cell culture a risky business? Risk analysis based on scientist survey data
International Journal of Cancer, 2016, 138, 664-670
4.37Citations (PDF)
36A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology
Cancer Research, 2016, 76, 7151-7159
3.833Citations (PDF)
37DNA methylation mediated up-regulation ofTERRAnon-coding RNA is coincident with elongated telomeres in the human placenta
Molecular Human Reproduction, 2016, 22, 791-799
2.933Citations (PDF)
38A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase
PLoS Genetics, 2015, 11, e1005286
3.242Citations (PDF)
39Stanniocalcin-1 Inhibits Renal Ischemia/Reperfusion Injury via an AMP-Activated Protein Kinase-Dependent Pathway
Journal of the American Society of Nephrology: JASN, 2015, 26, 364-378
0.482Citations (PDF)
40Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis
Clinical Epigenetics, 2015, 7,
3.932Citations (PDF)
41Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
Nature Structural and Molecular Biology, 2015, 22, 875-880
8.8205Citations (PDF)
42NuRD–ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination
Nature Structural and Molecular Biology, 2014, 21, 760-770
8.8121Citations (PDF)
43Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes
Nucleic Acids Research, 2014, 42, 1733-1746
15.5112Citations (PDF)
44Molecular characterization of collaborator of ARF (CARF) as a DNA damage response and cell cycle checkpoint regulatory protein
Experimental Cell Research, 2014, 322, 324-334
3.126Citations (PDF)
45Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
Proceedings of the National Academy of Sciences of the United States of America, 2014, 111,
7.536Citations (PDF)
46Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1
Blood, 2014, 124, 2767-2774
4.8116Citations (PDF)
47STC1 expression is associated with tumor growth and metastasis in breast cancer
Clinical and Experimental Metastasis, 2014, 32, 15-27
2.6111Citations (PDF)
48Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
Nature Genetics, 2013, 45, 371-384
25.2523Citations (PDF)
49STC1 Expression By Cancer-Associated Fibroblasts Drives Metastasis of Colorectal Cancer
Cancer Research, 2013, 73, 1287-1297
3.8166Citations (PDF)
50Alternative lengthening of telomeres: remodeling the telomere architecture
Frontiers in Oncology, 2013, 3,
2.682Citations (PDF)
51Alternative lengthening of telomeres in normal mammalian somatic cells
Genes and Development, 2013, 27, 18-23
4.6130Citations (PDF)
52Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
PLoS Genetics, 2012, 8, e1002772
3.2581Citations (PDF)
53Variant repeats are interspersed throughout the telomeres and recruit nuclear receptors in ALT cells
Journal of Cell Biology, 2012, 199, 893-906
5.4159Citations (PDF)
54Five dysfunctional telomeres predict onset of senescence in human cells
EMBO Reports, 2012, 13, 52-59
5.2210Citations (PDF)
55The role of telomere trimming in normal telomere length dynamics
Cell Cycle, 2012, 11, 1309-1315
3.256Citations (PDF)
56Detection of alternative lengthening of telomeres by telomere quantitative PCR
Nucleic Acids Research, 2012, 41, e34-e34
15.582Citations (PDF)
57Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length
PLoS ONE, 2012, 7, e46195
2.330Citations (PDF)
58Loss of Wild-Type ATRX Expression in Somatic Cell Hybrids Segregates with Activation of Alternative Lengthening of Telomeres
PLoS ONE, 2012, 7, e50062
2.371Citations (PDF)
59Telomerase activity in pleural malignant mesotheliomas
Lung Cancer, 2011, 73, 283-288
2.622Citations (PDF)
60Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers
PLoS ONE, 2011, 6, e24987
2.354Citations (PDF)
61Normal mammalian cells negatively regulate telomere length by telomere trimming
Human Molecular Genetics, 2011, 20, 4684-4692
2.999Citations (PDF)
62MicroRNA-296 is enriched in cancer cells and downregulates p21WAF1 mRNA expression via interaction with its 3' untranslated region
Nucleic Acids Research, 2011, 39, 8078-8091
15.544Citations (PDF)
63HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a
PLoS ONE, 2011, 6, e17036
2.327Citations (PDF)
64Presence of Alternative Lengthening of Telomeres Mechanism in Patients With Glioblastoma Identifies a Less Aggressive Tumor Type With Longer Survival
Journal of Neuropathology and Experimental Neurology, 2010, 69, 729-736
1.883Citations (PDF)
65Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers
FEBS Letters, 2010, 584, 3800-3811
2.7227Citations (PDF)
66Check your cultures! A list of cross‐contaminated or misidentified cell lines
International Journal of Cancer, 2010, 127, 1-8
4.3477Citations (PDF)
67Alternative lengthening of telomeres: models, mechanisms and implications
Nature Reviews Genetics, 2010, 11, 319-330
46.9936Citations (PDF)
68Senescence: an antiviral defense that is tumor suppressive?
Carcinogenesis, 2010, 31, 19-26
2.854Citations (PDF)
69Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres
Human Molecular Genetics, 2009, 18, 1017-1027
2.963Citations (PDF)
70Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins
Journal of Cell Biology, 2009, 185, 797-810
5.450Citations (PDF)
71DNA Replication Licensing and Progenitor Numbers Are Increased by Progesterone in Normal Human Breast
Endocrinology, 2009, 150, 3318-3326
2.5127Citations (PDF)
72Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription
Nucleic Acids Research, 2009, 37, 1152-1159
15.5146Citations (PDF)
73Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1
Journal of Cell Science, 2009, 122, 2989-2995
2.411Citations (PDF)
74Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning
Human Molecular Genetics, 2009, 18, 3098-3109
2.967Citations (PDF)
75Control of telomere length by a trimming mechanism that involves generation of t-circles
EMBO Journal, 2009, 28, 799-809
7.3194Citations (PDF)
76DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity
Nature Biotechnology, 2009, 27, 1181-1185
29.8487Citations (PDF)
77Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions
Nature Structural and Molecular Biology, 2009, 16, 1244-1251
8.8255Citations (PDF)
78Telomere uncapping and alternative lengthening of telomeres
Mechanisms of Ageing and Development, 2008, 129, 99-108
4.7112Citations (PDF)
79Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
Cancer Science, 2008, 99, 1092-1099
3.9162Citations (PDF)
80The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth
Endocrinology, 2008, 149, 2403-2410
2.596Citations (PDF)
81Disruption of Telomere Maintenance by Depletion of the MRE11/RAD50/NBS1 Complex in Cells That Use Alternative Lengthening of Telomeres
Journal of Biological Chemistry, 2007, 282, 29314-29322
2.2138Citations (PDF)
82Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis
International Journal of Cancer, 2006, 118, 2973-2980
4.3219Citations (PDF)
83The Murine Stanniocalcin 1 Gene Is Not Essential for Growth and Development
Molecular and Cellular Biology, 2005, 25, 10604-10610
2.562Citations (PDF)
84Suppression of Alternative Lengthening of Telomeres by Sp100-Mediated Sequestration of the MRE11/RAD50/NBS1 Complex
Molecular and Cellular Biology, 2005, 25, 2708-2721
2.5146Citations (PDF)
85Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome
Human Molecular Genetics, 2005, 14, 1785-1794
2.926Citations (PDF)
86hnRNP A2, a potential ssDNA/RNA molecular adapter at the telomere
Nucleic Acids Research, 2005, 33, 486-496
15.579Citations (PDF)
87The first molecular details of ALT in human tumor cells
Human Molecular Genetics, 2005, 14, R191-R196
2.9191Citations (PDF)
88Telomere Biology: A New Player in the End Zone
Current Biology, 2004, 14, R901-R902
3.628Citations (PDF)
89Molecular Markers and Long-term Survivors of Glioblastoma Multiforme
Cancer Journal (Sudbury, Mass ), 2004, 10, 333
1.81Citations (PDF)
90Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme
Lancet, The, 2003, 361, 836-838
62.1258Citations (PDF)
91Overexpressed mortalin (mot-2)/mthsp70/GRP75 and hTERT cooperate to extend the in vitro lifespan of human fibroblasts
Experimental Cell Research, 2003, 286, 96-101
3.196Citations (PDF)
92Alternative lengthening of telomeres, telomerase, and cancer
Cancer Letters, 2003, 194, 155-162
8.6181Citations (PDF)
93A Major Functional Difference between the Mouse and Human ARF Tumor Suppressor Proteins
Journal of Biological Chemistry, 2002, 277, 36665-36670
2.229Citations (PDF)
94CARF Is a Novel Protein That Cooperates with Mouse p19 (Human p14 ) in Activating p53
Journal of Biological Chemistry, 2002, 277, 37765-37770
2.262Citations (PDF)
95Hsp70 Family Member, mot-2/mthsp70/GRP75, Binds to the Cytoplasmic Sequestration Domain of the p53 Protein
Experimental Cell Research, 2002, 274, 246-253
3.1168Citations (PDF)
96Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit
Oncogene, 2002, 21, 128-139
6.5134Citations (PDF)
97Alternative lengthening of telomeres in mammalian cells
Oncogene, 2002, 21, 598-610
6.5603Citations (PDF)
98Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells
Nature Genetics, 2002, 30, 301-305
25.2121Citations (PDF)
99Telomere maintenance and cancer ? look, no telomerase
Nature Reviews Cancer, 2002, 2, 879-884
60.7142Citations (PDF)
100Title is missing!
2002
5Citations (PDF)
101Effects of Simian Virus 40 T-Antigens on Normal Human Mammary Epithelial Cells Reveal Evidence for Spontaneous Alterations in Addition to Loss of p16INK4a Expression
Experimental Cell Research, 2001, 265, 125-134
3.112Citations (PDF)
102An N-terminal Region of Mot-2 Binds to p53 In Vitro
Neoplasia, 2001, 3, 110-114
7.063Citations (PDF)
103Alternative Lengthening of Telomeres in Human Cells
Radiation Research, 2001, 155, 194-200
2.1104Citations (PDF)
104Pex19p Dampens the p19ARF-p53-p21WAF1 Tumor Suppressor Pathway*
Journal of Biological Chemistry, 2001, 276, 18649-18652
2.241Citations (PDF)
105Coexistence of Alternative Lengthening of Telomeres and Telomerase in hTERT-Transfected GM847 Cells
Molecular and Cellular Biology, 2001, 21, 3862-3875
2.5236Citations (PDF)
106Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells
Biochemical Journal, 2000, 350, 453-461
3.878Citations (PDF)
107Telomere maintenance by recombination in human cells
Nature Genetics, 2000, 26, 447-450
25.2832Citations (PDF)
108The role of senescence and immortalization in carcinogenesis
Carcinogenesis, 2000, 21, 477-484
2.8211Citations (PDF)
109Structurally and Functionally Distinct Mouse Hsp70 Family Members Mot-1 and Mot-2 Proteins are Encoded by Two Alleles
DNA Research, 2000, 7, 229-231
2.825Citations (PDF)
110Identification of a Novel Human Mitochondrial D-Loop RNA Species Which Exhibits Upregulated Expression Following Cellular Immortalization
Biochemical and Biophysical Research Communications, 2000, 276, 439-446
2.19Citations (PDF)
111Transcriptional Inactivation of p53 by Deletions and Single Amino Acid Changes in Mouse mot-1 Protein
Biochemical and Biophysical Research Communications, 2000, 279, 602-606
2.116Citations (PDF)
112p53 Localizes to the Centrosomes and Spindles of Mitotic Cells in the Embryonic Chick Epiblast, Human Cell Lines, and a Human Primary Culture: An Immunofluorescence Study
Experimental Cell Research, 2000, 256, 122-130
3.179Citations (PDF)
113Inactivation of p53 and life span extension of human diploid fibroblasts by mot-2
FEBS Letters, 2000, 474, 159-164
2.773Citations (PDF)
114The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
Neoplasia, 2000, 2, 426-432
7.0200Citations (PDF)
115p16INK4a and the control of cellular proliferative life span
Carcinogenesis, 1999, 20, 921-926
2.8102Citations (PDF)
116Cloning and Characterization of a Novel Gene,striamin, That Interacts with the Tumor Suppressor Protein p53
Journal of Biological Chemistry, 1999, 274, 14948-14955
2.25Citations (PDF)
117Constructing immortalized human cell lines
Current Opinion in Biotechnology, 1999, 10, 465-469
6.844Citations (PDF)
118Downregulation of metallothionein-IIA expression occurs at immortalization
Oncogene, 1999, 18, 897-903
6.523Citations (PDF)
119Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids
Oncogene, 1999, 18, 3383-3390
6.5103Citations (PDF)
120Expression and localisation of stanniocalcin 1 in rat bladder, kidney and ovary
Electrophoresis, 1999, 20, 2071-2076
2.619Citations (PDF)
121A reassessment of the telomere hypothesis of senescence
BioEssays, 1999, 20, 977-984
2.157Citations (PDF)
122Telomere maintenance mechanisms and cellular immortalization
Current Opinion in Genetics and Development, 1999, 9, 97-103
3.2173Citations (PDF)
123Telomere maintenance mechanisms and cellular immortalization
Current Opinion in Genetics and Development, 1999, 9, 247
3.20Citations (PDF)
124Identification of a 55-kDa Ezrin-Related Protein That Induces Cytoskeletal Changes and Localizes to the Nucleolus
Experimental Cell Research, 1999, 250, 51-61
3.127Citations (PDF)
125Genes Involved in the Control of Cellular Proliferative Potentiala
Annals of the New York Academy of Sciences, 1998, 854, 8-19
4.044Citations (PDF)
126Differential display of mRNA
Molecular Biotechnology, 1998, 10, 155-165
2.049Citations (PDF)
127Identification of a second stanniocalcin cDNA in mouse and human: Stanniocalcin 2
Molecular and Cellular Endocrinology, 1998, 141, 95-99
3.4110Citations (PDF)
128Telomere Length Dynamics in Telomerase-Positive Immortal Human Cell Populations
Experimental Cell Research, 1998, 239, 370-378
3.1109Citations (PDF)
129Human Stanniocalcin (STC): Genomic Structure, Chromosomal Localization, and the Presence of CAG Trinucleotide Repeats
Genomics, 1998, 47, 393-398
2.832Citations (PDF)
130Correction of the Copper Transport Defect of Menkes Patient Fibroblasts by Expression of the Menkes and Wilson ATPases
Journal of Biological Chemistry, 1998, 273, 31375-31380
2.2100Citations (PDF)
131Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member
Journal of Biological Chemistry, 1998, 273, 29586-29591
2.2214Citations (PDF)
132Isolation of a Candidate Human Telomerase Catalytic Subunit Gene, Which Reveals Complex Splicing Patterns in Different Cell Types
Human Molecular Genetics, 1997, 6, 2011-2019
2.9539Citations (PDF)
133The Telomere Lengthening Mechanism in Telomerase-Negative Immortal Human Cells Does Not Involve the Telomerase RNA Subunit
Human Molecular Genetics, 1997, 6, 921-926
2.9184Citations (PDF)
134Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines
Nature Medicine, 1997, 3, 1271-1274
33.01,245Citations (PDF)
135Reassessment of immortalization complementation group D
Experimental Gerontology, 1997, 32, 663-670
3.75Citations (PDF)
136Normal telomere maintenance in immortal ataxia telangiectasia cell lines
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997, 379, 177-184
1.829Citations (PDF)
137Genetic Differences between the Pancytosolic and Perinuclear Forms of Murine Mortalin
Experimental Cell Research, 1996, 226, 381-386
3.126Citations (PDF)
138Characteristics of tumor cell bioactivity in oncogenic osteomalacia
Molecular and Cellular Endocrinology, 1996, 124, 17-23
3.460Citations (PDF)
139Molecular cloning and characterization of mouse stanniocalcin cDNA
Molecular and Cellular Endocrinology, 1996, 124, 185-187
3.483Citations (PDF)
140Chromosomal changes and progressive tumorigenesis of human bronchial epithelial cell lines
Cancer Genetics and Cytogenetics, 1996, 92, 99-110
1.215Citations (PDF)
141Alterations in p53 and p16 INK4 Expression and Telomere Length during Spontaneous Immortalization of Li-Fraumeni Syndrome Fibroblasts
Molecular and Cellular Biology, 1995, 15, 4745-4753
2.5256Citations (PDF)
142A novel human cDNA highly homologous to the fish hormone stanniocalcin
Molecular and Cellular Endocrinology, 1995, 112, 241-247
3.4211Citations (PDF)
143Correlation between Complementation Group for Immortality and the Cellular Distribution of Mortalin
Experimental Cell Research, 1995, 216, 101-106
3.182Citations (PDF)
144HPV-16 E6 and E7 Genes, like SV40 Early Region Genes, Are Insufficient for Immortalization of Human Mesothelial and Bronchial Epithelial Cells
Experimental Cell Research, 1994, 213, 418-427
3.129Citations (PDF)
145Assignment of SV40-Immortalized Cells to More Than One Complementation Group for Immortalization
Experimental Cell Research, 1993, 205, 337-344
3.157Citations (PDF)
146Immortalization and characterization of human cell lines with mast cell and monocytic properties
British Journal of Haematology, 1993, 85, 452-461
2.76Citations (PDF)
147Human mesothelioma cells and asbestos-exposed mesothelial cells are selectively resistant to amosite toxicity: a possible mechanism for tumor promotion by asbestos
Carcinogenesis, 1992, 13, 1359-1363
2.88Citations (PDF)
148Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53
Experimental Cell Research, 1992, 203, 297-304
3.130Citations (PDF)
149Oncogenes and tumor-suppressor genes.
Environmental Health Perspectives, 1991, 93, 133-134
8.318Citations (PDF)
150A human bronchial epithelial cell strain with unusualin vitro growth potential which undergoes neoplastic transformation after SV40 T antigen gene transfection
International Journal of Cancer, 1991, 48, 764-773
4.311Citations (PDF)
151Oncogenes and Tumor-Suppressor Genes
Environmental Health Perspectives, 1991, 93, 133
8.32Citations (PDF)
152Enhancement of the invasive ability of a transformed human bronchial epithelial cell line by 12-O-tetra-decanoyl-phorbol-13-acetate and diacylglycerol
Carcinogenesis, 1989, 10, 2335-2338
2.819Citations (PDF)
153Invasive and Metastatic Potential of a v-Ha-ras-Transformed Human Bronchial Epithelial Cell Line
Journal of the National Cancer Institute, 1989, 81, 587-594
4.695Citations (PDF)
154Control of Growth and Squamous Differentiation in Normal Human Bronchial Epithelial Cells by Chemical and Biological Modifiers and Transferred Genes
Environmental Health Perspectives, 1989, 80, 209
8.33Citations (PDF)
155Human bronchial epithelial cells with integrated SV40 virus T antigen genes retain the ability to undergo squamous differentiation
Differentiation, 1988, 38, 60-66
2.4172Citations (PDF)
156Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral harvey ras
Molecular Carcinogenesis, 1988, 1, 151-160
3.168Citations (PDF)
157Strontium Phosphate Transfection of Human Cells in Primary Culture: Stable Expression of the Simian Virus 40 Large-T-Antigen Gene in Primary Human Bronchial Epithelial Cells
Molecular and Cellular Biology, 1987, 7, 2031-2034
2.535Citations (PDF)
158Cell cycle effects of iron depletion on T-47D human breast cancer cells
Experimental Cell Research, 1985, 161, 277-284
3.130Citations (PDF)
159Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flare
European Journal of Cancer & Clinical Oncology, 1984, 20, 1419-1424
0.7104Citations (PDF)
160N-Desmethyltamoxifen inhibits growth of MCF 7 human mammary carcinoma cells in Vitro
European Journal of Cancer & Clinical Oncology, 1983, 19, 1179-1181
0.78Citations (PDF)
161Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens
European Journal of Cancer & Clinical Oncology, 1983, 19, 307-318
0.791Citations (PDF)
162Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
European Journal of Cancer & Clinical Oncology, 1983, 19, 615-621
0.7187Citations (PDF)
163Title is missing!
0
2Citations (PDF)
164Federated Deep Learning Enables Cancer Subtyping by Proteomics
Cancer Discovery, 0, 15, 1803-1818
25.110Citations (PDF)
165Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification
Cancer Research Communications, 0, 5, 1879-1893
2.82Citations (PDF)
166Predictive Biomarkers of Antibody–Drug Conjugate Efficacy for Solid Tumors: Current Challenges and the Potential Role of Quantitative Proteomics
Clinical Cancer Research, 0, 32, 661-673
6.82Citations (PDF)
167OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology
Npj Precision Oncology, 0, 10,
6.51Citations (PDF)